Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / MYMD - MyMD says DEA found that its cannabinoid Supera-CBD is not a controlled substance

MYMD - MyMD says DEA found that its cannabinoid Supera-CBD is not a controlled substance

MyMD Pharmaceuticals Inc.

  • The US Drug Enforcement Agency has determined that MyMD Pharmaceuticals ( NASDAQ: MYMD ) experimental cannabinoid Supera-CBD is not a controlled substance.
  • The candidate is under development for anxiety, pain, addiction, and seizures.
  • Presently, with the exception of Jazz Pharmaceuticals ( JAZZ ) Epidiolex (cannabidiol), all FDA-approved cannabinoid products are listed as controlled substances.
  • MyMD said that Supera-CBD is a synthetic, non-toxic CBD analog that is an 8000x more potent CB2 agonist than plant-based CBD.

For further details see:

MyMD says DEA found that its cannabinoid Supera-CBD is not a controlled substance
Stock Information
Company Name: MyMD Pharmaceuticals Inc.
Stock Symbol: MYMD
Market: NASDAQ
Website: mymd.com
Menu
MYMD MYMD Quote MYMD Short MYMD News MYMD Articles MYMD Message Board
Get MYMD Alerts

News, Short Squeeze, Breakout and More Instantly...